Date
- Friday, 11 November 2016, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
A one-day workshop on spinal muscular atrophy (SMA) co-organised by the European Medicines Agency, SMA Europe and TREAT NMD. The workshop brings together key stakeholders to discuss, help and advance the development of therapies for the treatment of SMA. Topics for discussion include an overview of the disease, the pharmacology of the molecules under investigation, natural history data, clinical outcome measures and biomarkers.
Documents
Agenda - EMA - Spinal muscular atrophy workshop
English (EN) (88.56 KB - PDF)
Briefing Document to the Clinical Trial Readiness in Spinal Muscular Atrophy (SMA) SMA Europe, TREAT-NMD and European Medicines Agency meeting
English (EN) (1023.68 KB - PDF)
Appendix - Briefing Document to the Clinical Trial Readiness in Spinal Muscular Atrophy (SMA) SMA Europe, TREAT-NMD and European Medicines Agency meeting
English (EN) (155.12 KB - PDF)
List of participants - Spinal muscular atrophy stakeholder workshop
English (EN) (130.06 KB - PDF)
Presentation - General overview of novel experimental therapeutic approaches in SMA (Francesco Muntoni)
English (EN) (1.21 MB - PDF)
Presentation - Presentation - Biomarkers (Arthur Burghes)
English (EN) (905.11 KB - PDF)
Presentation - Session 2 discussion and questions (Richard Finkel, Eduardo Tizzano)
English (EN) (64.12 KB - PDF)
Presentation - Presentation - Industry perspective on drug development for Type 1 SMA (Kathie Bishop)
English (EN) (38.84 KB - PDF)
Presentation - Natural history of SMA and impact of standards of care on survival and motor function (Richard Finkel)
English (EN) (727 KB - PDF)
Presentation - SMA type I outcome measures (Basil Darras)
English (EN) (1.44 MB - PDF)
Presentation - Strategies for drug development in spinal muscular atrophy (SMA) Type 1 - A regulatory perspective (Marion Haberkamp)
English (EN) (1.17 MB - PDF)
Presentation - Exploratory outcome measures (including MRI) (Laurent Servais)
English (EN) (1.74 MB - PDF)
Presentation - Types 2 and 3 SMA: Industry perspective (Omar Khwaja)
English (EN) (296.64 KB - PDF)
Presentation - The evolving natural history of SMA types I and II (Eugenio Mercuri)
English (EN) (1.77 MB - PDF)
Presentation - Functional outcome measures for type 2 and 3 Spinal Muscular Atrophy (Anna Mayhew, Jacqueline Montes)
English (EN) (2.42 MB - PDF)
Presentation - Patient perspective to clinical benefit (Elena Mazzone)
English (EN) (1.46 MB - PDF)
Presentation - Patient perspective to clinical benefit (Kenneth Hobby, Luca Binetti)
English (EN) (2.87 MB - PDF)
Presentation - Registries and trial readiness (Hanns Lochmuller)
English (EN) (1.11 MB - PDF)
Presentation - Regulatory perspective (Mario Miguel Rosa)
English (EN) (292.02 KB - PDF)
Presentation - Standards of care in SMA and implications for clinical trials (Richard Finkel)
English (EN) (1.09 MB - PDF)
Multimedia
Video recording
A video recording is available.
To view use the 'Multimedia' tab.